MI-3 (Menin-MLL Inhibitor) is a potent menin-MLL interaction inhibitor with IC50 of 648 nM.  

GSK1324726A (I-BET726) is a highly selective inhibitor of BET family proteins with IC50 of 41 nM, 31 nM, and 22 nM for BRD2, BRD3, and BRD4, respectively.  

Remodelin is a potent acetyl-transferase NAT10 inhibitor.    

CPI-360 is a potent, selective,and SAM-competitive EZH1 inhibitor with IC50 of 102.3 nM, >100-fold selectivity over other methyltransferases.  

SP2509 is a selective histone demethylase LSD1 inhibitor with IC50 of 13nM, showing no activity against MAO-A, MAO-B, lactate dehydrogenase and glucose oxidase.  

OF-1 is a potent inhibitor of BRPF1B and BRPF2 bromodomain with Kd of 100 nM and 500 nM, respectively.  

GSK2879552 2HCl is a potent, selective, orally bioavailable, irreversible LSD1 inhibitor with Kiapp of 1.7 μM.

GSK503 is a potent and specific EZH2 methyltransferase inhibitor.